Cell Culture Media Market by Product (Serum-free, Chemically Defined, Classical, Xeno-free/Animal Component Free), Application (Monoclonal Antibody, Diagnostics, Cancer and Stem Cell Research), End User (Pharma & Biotech, Academic)- Global Forecast to 2029

The Cell Culture Media Market is expected to reach $14.64 billion by 2029, at a CAGR of 13.2% from 2022 to 2029. Cell growth requires a complex mixture of nutrients. Cell culture media provide these essential nutrients for in vitro mammalian cell culture. Cell culture media generally comprises an appropriate energy source and compounds that regulate the cell cycle. In addition to nutrients, the medium also helps maintain the pH and osmolality of the growing cells.

The growth of this market is driven by factors such as growing demand for monoclonal bodies, increasing prevalence of chronic diseases, growing funding for cell-based research, growing demand for biopharmaceuticals, and increasing R&D spending in the life science sector. Furthermore, the growing adoption of 3D cell culture, the growth potential of personalized medicine, and emerging economies are expected to provide significant opportunities for the growth of this market. However, ethical concerns regarding cell biology research and reproducibility of results challenge the growth of the market upto a certain extent.

COVID-19 Pandemic Impact: Cell Culture Media Market

In March 2020, the World Health Organization (WHO) declared the outbreak of COVID-19 a pandemic. Various established pharmaceutical & biopharmaceutical companies and small startups stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. Also, the economic and social burden of the pandemic drove government bodies to increase support for vaccine development and manufacturing, leading to an increase in the adoption of cell culture media for COVID-19 research.

As the global COVID-19 pandemic evolved, researchers tried to understand the biology of different virus variants to develop new therapeutic methods. This study process started in laboratory experiments to understand whether a drug can stop the virus from replicating in cells in a dish or whether a vaccine is effective on the virus. The experiments led to discoveries and new insights for developing treatments, vaccines, and diagnostic tools. On February 4, 2020, the Centers for Disease Control and Prevention (CDC) shipped the SARS-CoV-2 virus strain to the Biodefense and Emerging Infections Research (BEI) Resources Repository and was made available globally for researchers in the scientific and medical community to use the strain in their studies. Several vaccines or antiviral drugs for COVID-19 have been approved or are under development and manufacturing. This has increased the demand for cell culture products, including cell culture media.

For COVID-19-related projects, in vitro cell culture models played an important part in the study. Human lung epithelium models are currently being tested as a platform for COVID-19 research. The other models used are Normal Human Bronchial Epithelial Cells, Normal Human Small Airway Epithelial Cells, Tissue-specific Extracellular Matrices, and Airway Primary Endothelial Cells. The major areas of COVID-19 research were antiviral research, vaccine development, pathogenesis research, and virus stability research. Hence, COVID-19 positively impacted the growth of cell culture media products.

 Click here to: Get Free Sample Copy of this report 

Growing Funding for Cell-based Research to Drive Market Growth

Research studies help understand the response of cells towards any chemical. This study further helps find novel components that can be used globally for people's well-being. Also, these studies are carried out over a long period of time as standardization is needed when finding novel components. Such studies require investments, which further support more wide innovations in the medical field. For instance:

• In December 2021, the Novo Nordisk Foundation granted up to USD 355 million (EUR 300 million) for establishing an international research center focused on stem cell medicine.
• In June 2021, the Australian government announced an investment of USD 180 million in medical research projects around Australia to improve healthcare.
• In November 2020, the Canadian Institutes of Health Research announced investing more than USD 30 million over the next seven years, starting from 2020-2021, in a new research project. This project will be part of the initiative ‘100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes’. This will accelerate the development of stem cell-based therapies for treating Type 1 diabetes.
• In June 2020, nearly USD 228 million (EUR 200 million) was provided to help domestic research and manufacturing medicines.

These investments and support for cell-based research activities increase the demand for cell culture media products.

Key Findings of the Cell Culture Media Market Study

In 2022, the Serum-free Media Segment to Dominate the Cell Culture Media Market

Based on product, in 2022, the serum-free media segment is estimated to command the largest share of the cell culture market. The easy downstream processing of components after production from media, increased demand for various recombinant proteins & types of culture, and rising antibody production leading to serum-free hybridoma adoption are some of the major factors driving the growth of this segment.

In 2022, the Bioproduction Segment to Dominate the Cell Culture Media Market

Based on application, the bioproduction segment is estimated to command the largest share of the cell culture media market in 2022. The major factor contributing to the large market share of this segment is the rising number of chronic diseases globally. In such situation, biotherapeutics are used for treating chronic diseases  which increased their production and simultaneously the usage of cell culture media for the bioproduction.

In 2022, the Pharmaceutical & Biotechnology Companies Segment to Dominate Cell Culture Media Market

In 2022, the pharmaceutical & biotechnology companies segment is estimated to account for the largest share of the cell culture media market. Factors such as the expansion of production & cell culture facilities, the growing focus on cell-based pharmaceutical research activities, and the rising number of biotech start-ups are some of the factors driving the growth of this segment.

Asia-Pacific: Fastest-growing Regional Market

Based on geography, Asia-Pacific is expected to register the highest growth rate during the forecast period. The growth is attributed to the rising technological advancements in biotechnology & pharmaceutical centers, growing focus on developing vaccines & clinical research activities, the presence of major research organizations, low manufacturing & labor costs, and developing healthcare infrastructure.

Key Players

The key players profiled in the cell culture media market study are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), FUJIFILM Holdings Corporation (Japan),  Agilent Technologies, Inc. (U.S.),  Miltenyi Biotec B.V. & Co. KG (Germany), BIOLOGOS (U.S.), STEMCELL Technologies Inc. (Canada), and Cell Applications, Inc. (U.S.).

Scope of the Report:

Cell Culture Media Market, by Product

• Serum-free Media
• Chemically-defined Media
• Classical Media
• Animal Component-free Media
• Other Cell Culture Media

Cell Culture Media Market, by Application

• Bioproduction
  • Monoclonal Antibody Production
  • Therapeutic Protein Production
  • Vaccine Production
  • Cell and Gene therapy
• Diagnostics
• Cancer Research
• Drug Screening and Development
• Stem Cell Research

Cell Culture Media Market, by End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Diagnostic Laboratories

Cell Culture Media Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Key questions answered in the report: